NYSE:BHVNBiotechs
Biohaven (BHVN) Valuation Check After Q1 Results And New Shelf Registration
Biohaven (BHVN) is back in focus after reporting first quarter results alongside filing an omnibus shelf registration, pairing a reduced net loss with fresh flexibility to issue a wide range of securities.
See our latest analysis for Biohaven.
Those first quarter results and the new shelf registration arrive after a sharp reset, with the share price down 25.57% over 90 days and total shareholder return down 55.84% over one year. This points to fading momentum despite recent balance sheet...